Skip to main content
Top
Published in: Pathology & Oncology Research 3/2015

Open Access 01-07-2015 | Research

HPV-Type Distribution and Reproducibility of Histological Diagnosis in Cervical Neoplasia in Poland

Authors: Andrzej Nowakowski, Sabrina Collas de Souza, Robert Jach, Dominique Rosillon, Alicja Książek, Katsiaryna Holl

Published in: Pathology & Oncology Research | Issue 3/2015

Login to get access

Abstract

This study was performed to assess attribution of high grade cervical intraepithelial neoplasia (HG-CIN) and invasive cervical cancer (ICC) to human papillomavirus (HPV) genotypes and secondarily to assess reproducibility of HG-CIN/ICC diagnosis obtained in Poland. Formaldehyde fixed, paraffin embedded blocks of HG-CIN/ICC from two distant institutions were sent to a central laboratory together with original histological diagnoses. Central/expert review of histopathological specimens was performed and agreement between local and central/expert diagnoses was calculated. HPV detection and genotyping in the samples was carried out with the use of SPF10-LiPA25 technology. Results were analyzed for 205 HG-CIN and 193 ICC cases with centrally confirmed diagnoses. Kappa coefficients and 95 % confidence intervals for HG-CIN and ICC diagnoses were: 0.13 (0.09;0.17) and 0.19 (0.11;0.26) respectively. Cohen’s kappa coefficients for lesions with representative number of samples ranged from 0.01 for cervical intraepithelial neoplasia grade 2 to 0.75 for adenocarcinoma. HPV DNA was detected in 96.1 and 91.2 % of the confirmed HG-CIN and ICC specimens respectively. HPV positive HG-CIN was most commonly attributed to HPV types: 16 (62.8), 33 (7.8), 31 (6.6), 52 (3.7), 45 (2.6) and 58 (2.6 %). HPV positive ICC was most commonly attributed to HPV types: 16 (72.1), 18 (10.8), 33 (5.7), 45 (3.4) and 31 (1.7 %). Reproducibility of histological diagnosis of HG-CIN/ICC obtained in Poland generally increases with the severity of lesion and is lowest for cervical intraepithelial neoplasia grade 2 and highest for adenocarcinoma. Over 80 % of ICC cases are vaccine-preventable in Poland.
Literature
1.
go back to reference Spaczyński M, Karowicz-Bilinska A, Rokita W et al (2010) Attendance rate in the polish cervical cancer screening program in the years 2007–2009. Ginekol Pol 81:655–663PubMed Spaczyński M, Karowicz-Bilinska A, Rokita W et al (2010) Attendance rate in the polish cervical cancer screening program in the years 2007–2009. Ginekol Pol 81:655–663PubMed
3.
go back to reference Nowakowski A, Jackowska T, Oszukowski P, Radowicki S, Wysocki J, Zatoński W (2013) Prevention of cervical cancer – an interdisciplinary problem. Can we improve the situation in Poland and how? Pediatr Pol 88:340–346CrossRef Nowakowski A, Jackowska T, Oszukowski P, Radowicki S, Wysocki J, Zatoński W (2013) Prevention of cervical cancer – an interdisciplinary problem. Can we improve the situation in Poland and how? Pediatr Pol 88:340–346CrossRef
5.
go back to reference Kedzia W, Pruski D, Józefiak A, Rokita W, Spaczyński M (2010) Genotyping of oncogenic human papilloma viruses in women with HG SIL diagnosis. Ginekol Pol 81:740–744PubMed Kedzia W, Pruski D, Józefiak A, Rokita W, Spaczyński M (2010) Genotyping of oncogenic human papilloma viruses in women with HG SIL diagnosis. Ginekol Pol 81:740–744PubMed
6.
go back to reference Bardin A, Vaccarella S, Clifford GM et al (2008) Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44:557–564CrossRefPubMed Bardin A, Vaccarella S, Clifford GM et al (2008) Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44:557–564CrossRefPubMed
7.
go back to reference Liss J, Łukaszuk K, Gulczyński J et al (2002) The incidence of human papilloma virus (HPV) DNA in patients with cervical carcinoma from Gdansk region. Ginekol Pol 73:740–744PubMed Liss J, Łukaszuk K, Gulczyński J et al (2002) The incidence of human papilloma virus (HPV) DNA in patients with cervical carcinoma from Gdansk region. Ginekol Pol 73:740–744PubMed
8.
go back to reference Tjalma WA, Fiander A, Reich O et al (2013) Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 132:854–867CrossRefPubMed Tjalma WA, Fiander A, Reich O et al (2013) Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 132:854–867CrossRefPubMed
9.
go back to reference Tavassoli FA, Devilee P (2003) World health organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon Tavassoli FA, Devilee P (2003) World health organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
10.
go back to reference Insinga RP, Liaw KL, Johnson LG, Madeleine MM (2008) A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 17:1611–1622CrossRefPubMedCentralPubMed Insinga RP, Liaw KL, Johnson LG, Madeleine MM (2008) A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 17:1611–1622CrossRefPubMedCentralPubMed
11.
go back to reference Wentzensen N, Schiffman M, Dunn T et al (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125:2151–2158CrossRefPubMedCentralPubMed Wentzensen N, Schiffman M, Dunn T et al (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125:2151–2158CrossRefPubMedCentralPubMed
12.
go back to reference de Sanjose S, Quint WG, Alemany L et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056CrossRefPubMed de Sanjose S, Quint WG, Alemany L et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056CrossRefPubMed
13.
go back to reference Saslow D, Solomon D, Lawson HW et al (2012) ACS-ASCCP-ASCP cervical cancer guideline committee. American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 62:147–172CrossRefPubMedCentralPubMed Saslow D, Solomon D, Lawson HW et al (2012) ACS-ASCCP-ASCP cervical cancer guideline committee. American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 62:147–172CrossRefPubMedCentralPubMed
14.
go back to reference Arbyn M, Kyrgiou M, Simoens C et al (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337:a1284CrossRefPubMedCentralPubMed Arbyn M, Kyrgiou M, Simoens C et al (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337:a1284CrossRefPubMedCentralPubMed
15.
go back to reference Dalla Palma P, Giorgi Rossi P, Collina G et al (2009) The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study. Am J Clin Pathol 132:125–132CrossRefPubMed Dalla Palma P, Giorgi Rossi P, Collina G et al (2009) The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study. Am J Clin Pathol 132:125–132CrossRefPubMed
16.
go back to reference Castle PE, Stoler MH, Solomon D, Schiffman M (2007) The relationship of community iopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 127:805–815CrossRefPubMed Castle PE, Stoler MH, Solomon D, Schiffman M (2007) The relationship of community iopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 127:805–815CrossRefPubMed
17.
go back to reference Kato I, Santamaria M, De Ruiz PA et al (1995) Inter-observer variation in cytological and histological diagnoses of cervical neoplasia and its epidemiologic implication. J Clin Epidemiol 48:1167–1174CrossRefPubMed Kato I, Santamaria M, De Ruiz PA et al (1995) Inter-observer variation in cytological and histological diagnoses of cervical neoplasia and its epidemiologic implication. J Clin Epidemiol 48:1167–1174CrossRefPubMed
20.
go back to reference Klaes R, Benner A, Friedrich T et al (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26:1389–1399CrossRefPubMed Klaes R, Benner A, Friedrich T et al (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26:1389–1399CrossRefPubMed
21.
go back to reference Pinto AP, Schlecht NF, Woo TY, Crum CP, Cibas ES (2008) Biomarker (ProEx C, p16 (INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol 21:1067–1074CrossRefPubMed Pinto AP, Schlecht NF, Woo TY, Crum CP, Cibas ES (2008) Biomarker (ProEx C, p16 (INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol 21:1067–1074CrossRefPubMed
22.
go back to reference Dijkstra MG, Heideman DA, de Roy SC et al (2010) p16 (INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol 63:972–977CrossRefPubMed Dijkstra MG, Heideman DA, de Roy SC et al (2010) p16 (INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol 63:972–977CrossRefPubMed
Metadata
Title
HPV-Type Distribution and Reproducibility of Histological Diagnosis in Cervical Neoplasia in Poland
Authors
Andrzej Nowakowski
Sabrina Collas de Souza
Robert Jach
Dominique Rosillon
Alicja Książek
Katsiaryna Holl
Publication date
01-07-2015
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2015
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-014-9877-4

Other articles of this Issue 3/2015

Pathology & Oncology Research 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine